Humana Stock Today

HUM Stock  USD 486.22  9.65  2.02%   
Market Performance
0 of 100
Odds Of Distress
Less than 9
Humana is selling at 486.22 as of the 7th of February 2023; that is 2.02 percent increase since the beginning of the trading day. The stock's lowest day price was 480.63. Humana has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Humana Inc are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 8th of January 2023 and ending today, the 7th of February 2023. Click here to learn more.
CUSIP
444859102
Fiscal Year End
December
Business Domain
Health Care Equipment & Services
IPO Date
22nd of January 1993
Category
Healthcare
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky. Humana operates under Healthcare Plans classification in the United States and is traded on New York Stock Exchange. The company has 124.97 M outstanding shares of which 2.44 M shares are currently shorted by investors with about 2.57 days to cover. More on Humana Inc

Moving together with Humana

+0.84CVSCVS Health Corp Earnings Call TomorrowPairCorr

Moving against Humana

-0.61SQBlock Inc Aggressive PushPairCorr
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores

Humana Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Humana's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Humana or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary, Humana's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Humana's managers, analysts, and investors.
Environment Score
Governance Score
Social Score
ChairmanKurt Hilzinger
Thematic IdeaHealthcare (view all)
Fama & French Classification
Average Analyst Recommendation
Analysts covering Humana report their recommendations after researching Humana's financial statements, talking to executives and customers, or listening in on Humana's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Humana Inc. The Humana consensus assessment is calculated by taking the average forecast from all of the analysts covering Humana.
Piotroski F Score
Piotroski F-Score is a popular financial indicator that puts together nine criteria to evaluate the financial strength of Humana Inc based on its profitability, leverage, liquidity, source of funds, and operating efficiency. It is an academic score (developed by Joseph Piotroski in 2002) to determine the current strength of Humana Inc financial position. Scores of 8 and 9 are usually classified as strong value stocks, whereas scores of 2 or below are considered weak value stocks.
HealthyDetails
Current ValueLast YearChange From Last Year 10 Year Trend
Weighted Average Shares Diluted165.1 M148.8 M
Significantly Up
Down
Slightly volatile
Weighted Average Shares163.9 M148 M
Significantly Up
Down
Slightly volatile
Return on Average Assets6.486.66
Fairly Down
Up
Pretty Stable
Net Cash Flow from Operations2.2 BB
Notably Up
Up
Slightly volatile
Current Liabilities14.6 B17.6 B
Significantly Down
Up
Slightly volatile
Total Liabilities27.5 B25.5 B
Significantly Up
Up
Slightly volatile
Gross Margin0.170.15
Moderately Up
Down
Slightly volatile
Total Debt15.9 B14.7 B
Significantly Up
Up
Slightly volatile
Asset Turnover1.911.88
Fairly Up
Down
Pretty Stable
Current Assets24.8 B28.6 B
Fairly Down
Up
Slightly volatile
Total Assets31.9 B39.9 B
Significantly Down
Up
Slightly volatile
Macroaxis Advice
The buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Humana's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Strong HoldFairly Valued
Financial Strength
Humana's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Humana's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Humana's bond ratings measure its overall creditworthiness, which in many ways corresponds to the cost of borrowing for an issuer. These ratings assign a letter grade to all of Humana's outstanding corporate bonds that indicate their credit quality. We use reports published by private self-sufficient rating services such as Standard & Poor's or Fitch Ratings Inc. to evaluate a bond issuer's financial strength or its ability to pay a bond's principal and interest.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Humana's financial leverage. It provides some insight into what part of Humana's total assets is financed by creditors.
By using current balance sheet information, investors can analyze the liability, assets, and equity on Humana's books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how Humana deploys its capital and how much of that capital is borrowed.
Liquidity
Humana cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company has 9.03 B in debt with debt to equity (D/E) ratio of 0.85, which is OK given its current industry classification. Humana Inc has a current ratio of 1.5, which is typical for the industry and considered as normal. Debt can assist Humana until it has trouble settling it off, either with new capital or with free cash flow. So, Humana's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Humana Inc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Humana to invest in growth at high rates of return. When we think about Humana's use of debt, we should always consider it together with cash and equity.

Operating Cash Flow

2.19 Billion
Humana Inc (HUM) is traded on New York Stock Exchange in USA and employs 62 people. Humana is listed under Health Care Providers & Services category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a total capitalization of 60.77 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Humana's market, we take the total number of its shares issued and multiply it by Humana's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Humana Inc runs under Health Care Providers & Services sector within Health Care industry. The entity has 124.97 M outstanding shares of which 2.44 M shares are currently shorted by investors with about 2.57 days to cover. Humana Inc has about 5.06 B in cash with 4.59 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 143.73.
Check Humana Probability Of Bankruptcy
Ownership
Humana Inc has a total of one hundred twenty-four million nine hundred seventy-five thousand outstanding shares. The majority of Humana Inc outstanding shares are owned by outside corporations. These institutional investors are usually referred to as non-private investors looking to purchase positions in Humana to benefit from reduced commissions. Consequently, third-party entities are subject to a different set of regulations than regular investors in Humana Inc. Please pay attention to any change in the institutional holdings of Humana Inc as this could imply that something significant has changed or about to change at the company. Please note that no matter how much assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Ownership Allocation

Check Humana Ownership Details

Humana Stock Price Odds Analysis

Contingent on a normal probability distribution, the odds of Humana jumping above the current price in 90 days from now is about 89.91%. The Humana Inc probability density function shows the probability of Humana stock to fall within a particular range of prices over 90 days. Considering the 90-day investment horizon Humana has a beta of 0.3241. This usually indicates as returns on the market go up, Humana average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Humana Inc will be expected to be much smaller as well. Additionally, the company has a negative alpha, implying that the risk taken by holding this instrument is not justified. Humana Inc is significantly underperforming NYSE Composite.
  Odds Below 486.22HorizonTargetOdds Above 486.22
9.98%90 days
 486.22 
89.91%
Based on a normal probability distribution, the odds of Humana to move above the current price in 90 days from now is about 89.91 (This Humana Inc probability density function shows the probability of Humana Stock to fall within a particular range of prices over 90 days) .

Humana Historical Income Statement

Humana Inc Income Statement is one of the three primary financial statements used for reporting Humana's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Humana Inc revenue and expense. Humana Income Statement primarily focuses on the company's revenues and expenses during a particular period.
Humana Weighted Average Shares is very stable at the moment as compared to the past year. Humana reported last year Weighted Average Shares of 147.99 Million. As of 7th of February 2023, Weighted Average Shares Diluted is likely to grow to about 165.1 M, while Cost of Revenue is likely to drop about 67.9 B. View More Fundamentals

Humana Stock Against Markets

Picking the right benchmark for Humana stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Humana stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Humana is critical whether you are bullish or bearish towards Humana Inc at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Humana without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Fundamental Analysis Now

   

Fundamental Analysis

View fundamental data based on most recent published financial statements
All  Next Launch Module

Humana Corporate Directors

Humana corporate directors refer to members of a Humana board of directors. The board of directors generally takes responsibility for the Humana's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Humana's board members must vote for the resolution. The Humana board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
David Jones - Independent DirectorProfile
David Nash - Independent DirectorProfile
David Feinberg - Independent DirectorProfile
Marissa Peterson - Independent DirectorProfile

Invested in Humana Inc?

The danger of trading Humana Inc is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Humana is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Humana. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Humana Inc is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Please check Risk vs Return Analysis. You can also try Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

Complementary Tools for analysis

When running Humana Inc price analysis, check to measure Humana's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Humana is operating at the current time. Most of Humana's value examination focuses on studying past and present price action to predict the probability of Humana's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Humana's price. Additionally, you may evaluate how the addition of Humana to your portfolios can decrease your overall portfolio volatility.
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Transaction History
View history of all your transactions and understand their impact on performance
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Global Correlations
Find global opportunities by holding instruments from different markets
Is Humana's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Humana. If investors know Humana will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Humana listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.21) 
Market Capitalization
60.8 B
Quarterly Revenue Growth
0.066
Return On Assets
0.0543
Return On Equity
0.1781
The market value of Humana Inc is measured differently than its book value, which is the value of Humana that is recorded on the company's balance sheet. Investors also form their own opinion of Humana's value that differs from its market value or its book value, called intrinsic value, which is Humana's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Humana's market value can be influenced by many factors that don't directly affect Humana's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Humana's value and its price as these two are different measures arrived at by different means. Investors typically determine Humana value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Humana's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.